The graphite market was dominated by oversupply, trade disputes and China’s continued grip in…
Jordan Roy-Byrne, CMT, MFTA, editor and publisher of the Daily Gold, discusses how long…
Here are some charts that reflect our areas of focus this week at XLU…
Latest News
-
-
The U.S. Food and Drug Administration (FDA) announced it is initiating the removal of…
-
The ball is rolling to reopen the government, but there is still much left…
-
Speaker Mike Johnson, R-La., is anticipating the House could vote to end the government…
-
Lawyers for roughly two dozen states will head to court Monday to block the…
-
The shutdown stalemate that has dragged on in the Senate officially ended late Monday…
-
Mark Skousen of Forecasts & Strategies shares his outlook for gold, silver and the…
-
Investing
InMed Pharmaceuticals: Innovating Cannabinoid-inspired Medicines, Backed by Real Revenue and Clear Path to Value
InMed Pharmaceuticals (NASDAQ: INM) pairs innovative therapeutic development in Alzheimer’s, ophthalmology, and dermatology with…